Picture of Insight Molecular Diagnostics logo

IMDX — Insight Molecular Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oncocyte Reports Second Quarter 2022 Financial Results

Aug 10 (Reuters) - OncoCyte Corp  OCX.O :
    * ONCOCYTE REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.07
    * Q2 REVENUE $2.1 MILLION
    * TOTAL REVENUE WAS $2.1 MILLION FOR Q2 OF 2022, COMPARED TO
$1.4
MILLION FOR PRIOR QUARTER
    * QTRLY NET LOSS PER SHARE WAS $0.07
    * Q2 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $2.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9DlmTj 
Further company coverage:  OCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Insight Molecular Diagnostics

See all news